New data on secondary prevention of myocardial infarction in Spain.: Results of the PREVESE II Study
New data on secondary prevention of myocardial infarction in Spain.: Results of the PREVESE II Study
复制标题
DOI：
10.1016/s0300-8932(02)76708-0
复制
发表时间：
2002-08-01
影响因子：
5.9
通讯作者：
Sellers, MD
中科院分区：
文献类型：
--
作者：
de Velasco, JA;Cosín, J;Sellers, MD
引言和目标。PREVESE研究报告了西班牙心肌梗死后的二级预防情况。在欧洲进行的类似调查也表明，二级预防的实施不够充分。第二次PREVESE研究的目的是比较第一次研究四年后西班牙的情况。患者和方法。我们回顾了来自西班牙74家医院的2,054名心肌梗塞后出院的患者。我们研究了出院后医疗记录中记录的可用信息、危险因素的流行率、所进行的操作以及入院前和出院时的医疗治疗。我们将收集的数据与第一次PREVESE研究的数据进行了比较，因为数据收集方法相似。医院病历中记录的最重要危险因素(高血压94.8%；血脂异常和糖尿病97.9%；吸烟89.2%)的信息令人满意。与之前的研究相比，吸烟者的比例显著下降(46.1%比35.4%)。超声心动图检查频率更高(60.1vs.85.6%)，与药物、出院时的治疗方式也有显著差异，其中β-受体阻滞剂(33.5vs.45.1%)、血管紧张素转换酶抑制剂(32.5vs.46.4%)和降脂药物(6.7vs.30.5%)的处方显著增加。这项研究表明，心肌梗死患者的管理在四年后有所改善，主要是因为出院时开了更多的心脏保护药物。
Introduction and objectives. The PREVESE Study reported the situation of secondary prevention after myocardial infarction in Spain. Similar surveys conducted in Europe have also shown that the implementation of secondary prevention is not adequate. The aim of this second PREVESE study was to compare the situation in Spain four years after the first study.Patients and method. We included retrospectively 2,054 patients discharged after myocardial infarction from 74 Spanish hospitals. We studied the available information recorded in medical records after discharge, the prevalence of risk factors, procedures performed, and medical treatment before admission and at discharge. We compared the data collected with those from the first PREVESE study because the data collection methodology was similar.Results. The information recorded in the hospital medical records was satisfactory in relation to the most important risk factors (hypertension 94.8%; dyslipidemia and diabetes 97.9%; and smoking 89.2%). Compared with the previous study, there was a significant decrease in the percentage of smokers (46.1 vs. 35.4%). The echocardiogram was performed more frequently (60.1 vs. 85.6%) and there were also significant differences related to drug,treatment at discharge, with an important increase in the prescription of beta-blockers (33.5 vs. 45.1%), ACE inhibitors (32.5 vs. 46.4%), and lipid-lowering drugs (6.7 vs 30.5%).Conclusions. This study shows some improvement in the management of myocardial infarction patients after a four-year period, mainly due to more prescription of cardioprotective drugs at hospital discharge.